# Pharmaceutical Innovations, Inc.

- Location (FDA's records): Newark, NJ
- FDA decisions: 5 (1996–2018): 5 510(k) clearances
- Product codes: MUI (4), KMJ (1)
- 510(k) review time since 2016: median 435 days, against 434 for FDA's reviews in the same codes and years (0 of 4 faster)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Quotient Medical: 4 (https://510kreport.com/company/quotient-medical)
- Eco-Med Pharmaceuticals, Inc.: 2 (https://510kreport.com/company/eco-med-pharmaceuticals)

## Firms that cite its devices most
- Juniper Medical, Inc.: 1 (https://510kreport.com/company/juniper-medical)
- Foshan Pingchuang Medical Technology Co., Ltd.: 1 (https://510kreport.com/company/foshan-pingchuang-medical-technology)

## Its most-cited devices
- K961222: Evron Gel (1996), cited by 1
- K163026: Ultra/Phonic Scanning Gel (2018), cited by 1

## Recent decisions
- K163026: Ultra/Phonic Scanning Gel (Jan 9, 2018)
- K163027: Ultra/Phonic Free Conductivity Gel (Jan 9, 2018)
- K163024: Ultra/Phonic Conductivity Gel (Jan 8, 2018)
- K163023: Other-Sonic Transmission Gel (Jan 8, 2018)
- K961222: Evron Gel (Jun 26, 1996)

Source page: https://510kreport.com/company/pharmaceutical-innovations